2025年4月18日 周五
Home > Archive>Volume 26, Issue 8, 2018 >858-864
PDF HTML XML Export Cite reminder
Antiplatelet agent therapy for myocardial infarction complicated with cerebral infarction
CSTR:
[cstr]
Author:
Affiliation:

1.Graduate School of Hebei Medical University, Shijiazhuang, Hebei 050051, China;2.Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050051, China;3.Geriatric Department, Hebei Provincial People's Hospital, Shijiazhuang, Hebei 050051, China;4.Clinical Laboratory, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, China)

Clc Number:

R543

  • Article
    • | |
  • Metrics
    • |
  • Reference
    • |
  • Related
    • |
  • Cited by
    • | |
  • Comments
    Abstract:

    Myocardial infarction and cerebral infarction are the vascular diseases that are currently and seriously endangering human health, and the mortality rate is the first cause of death. The development of thrombosis after atherosclerotic lesions is a common underlying process for a variety of progressive manifestations caused by cardiovascular and cerebrovascular diseases (coronary artery disease and cerebrovascular disease). For the drug treatment to patients with atherosclerosis, the antiplatelet therapy is deemed as the cornerstone. In the past two decades, significant progress has been achieved in antiplatelet drug therapy, especially for coronary artery disease patients. However, it is difficult to definitely determine the risks and benefits of antiplatelet drug combinations for coronary artery disease and cerebrovascular disease patients, since the risk of ischemia and hemorrhage incurred in patients with coronary artery disease is to be increased during the treatment. This article provides the current evidence for the forefront of antiplatelet therapy, and the progress of antiplatelet drugs for thrombosis events in two stage prevention of coronary artery disease and cerebrovascular disease on the basis of atherosclerotic lesions.

    Reference
    Related
    Cited by
Get Citation

LIU Xiaoye, LI Gang, HU Rui, LI Xiaotong, JI Xin. Antiplatelet agent therapy for myocardial infarction complicated with cerebral infarction[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(8):858-864.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 24,2017
  • Revised:January 08,2018
  • Online: July 17,2018
Article QR Code

You are the 32729 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025